ArticleFrontiers in neurology2023

Results of treatment with alemtuzumab in a Spanish cohort of patients with multiple sclerosis in the real world: The RealMS study.

Sara Eichau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.